Status:
COMPLETED
Quantiferon for Detection of Latent Tuberculosis in Healthcare Workers
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Tuberculosis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The accuracy of tuberculin skin test (TST) for detecting latent tuberculosis is limited in countries with a high proportion of population having received vaccination with the BCG. We aim to determine ...
Detailed Description
The QUANTIPS study includes two components: 1. survey of HCWs working in high-risk units (respiratory diseases or infectious diseases with at least 5 case of smear-positive pulmonary tuberculosis par...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Group 1:
- Healthcare worker volunteering for the study
- Stable (expected employment in the unit \> one year)
- Working in a high-risk units for tuberculosis (at least 5 cases of smear-positive pulmonary tuberculosis per year)
- Group 2 :
- Healthcare worker volunteering for the study
- With an unexpected exposure to a patient with contagious tuberculosis (delay in respiratory isolation of a smear-positive patient)
- EXCLUSION CRITERIA:
- No informed consent
- Age \< 18 years
- Employment in this unit \< one year
Exclusion
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
1024 Patients enrolled
Trial Details
Trial ID
NCT00797836
Start Date
November 1 2008
End Date
November 1 2010
Last Update
January 10 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Bichat Claude Bernard
Paris, Île-de-France Region, France, 75018